D
Diego Cantarovich
Researcher at University of Nantes
Publications - 143
Citations - 5384
Diego Cantarovich is an academic researcher from University of Nantes. The author has contributed to research in topics: Transplantation & Kidney transplantation. The author has an hindex of 32, co-authored 122 publications receiving 5080 citations. Previous affiliations of Diego Cantarovich include French Institute of Health and Medical Research.
Papers
More filters
Journal Article
Placebo-controlled study of mycophenolate mofetil combined with cyclosporine and corticosteroids for prevention of acute rejection
Josep M. Grinyó,Carl-Gustav Groth,Rudolf Pichlmayr,Sa Sadek,Yves Vanrenterghem,M Behrend,R Luck,Francesc Moreso,J Peeters,J Rodicio,J Morales,Dagfinn Albrechtsen,P Fauchald,Sameh S. Sadek,J. P. A. Lodge,Jp Soulillou,Diego Cantarovich,van Willem Son,Adam Tegzess,Karl-Heinz Wagner,J Erhard,Christina Brattström,Lars Mjörnstedt,M. Wiesel,S. Carl,Hh Neumayer,Hauser,Peter Lang,B Bourgeon,Gunnar Tufveson,G. Gannedahl,Henrik Ekberg,N. Persson,A Tarantino,M Campise,G Thiel,M Zeiler,R Hene,G Ligtenberg,A Morgan,K Rigg,Hooftman L,K Hutchinson +42 more
TL;DR: MMF significantly reduced the rate of biopsy-proven rejection or other treatment failure during the first 6 months after transplantation and was well tolerated, although the 3 g dose was somewhat less well tolerated.
Journal ArticleDOI
Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens
Jacques Dantal,Maryvonne Hourmant,Diego Cantarovich,Magali Giral,Gilles Blancho,Brigitte Dréno,Jean-Paul Soulillou +6 more
TL;DR: It is found that halving of trough blood cyclosporin concentrations significantly changes graft function or graft survival, and the design of long-term maintenance protocols for transplant recipients based on powerful immunosuppressant combinations should take these potential risks into account.
Journal ArticleDOI
Frequency and Clinical Implications of Development of Donor-Specific and Non–Donor-Specific HLA Antibodies after Kidney Transplantation
Maryvonne Hourmant,Anne Cesbron-Gautier,Paul I. Terasaki,Kazuo Mizutani,Anne Moreau,Aurélie Meurette,Jacques Dantal,Magali Giral,Gilles Blancho,Diego Cantarovich,Georges Karam,Gilles Folléa,Jean-Paul Soulillou,Jean-Denis Bignon +13 more
TL;DR: Screening of HLA antibodies posttransplantation could be a good tool for the follow-up of patients who receive a kidney transplant and allow immunosuppression to be tailored.
Journal ArticleDOI
Randomized Controlled Trial of a Monoclonal Antibody against the Interleukin-2 Receptor (33B3.1) as Compared with Rabbit Antithymocyte Globulin for Prophylaxis against Rejection of Renal Allografts
J. P. Soulillou,Diego Cantarovich,B. Le Mauff,Magali Giral,N Robillard,M. Hourmant,Michel Hirn,Yannick Jacques +7 more
TL;DR: It is concluded that 33B3.1 is as effective as antithymocyte globulin in the prevention of renal-transplant rejection, and its use results in fewer infections and side effects.
Journal ArticleDOI
Delayed graft function of more than six days strongly decreases long-term survival of transplanted kidneys
Magali Giral-Classe,Maryvonne Hourmant,Diego Cantarovich,Jacques Dantal,Gilles Blancho,Pascal Daguin,Daria Ancelet,Jean-Paul Soulillou +7 more
TL;DR: It is shown that the need for dialysis is not an adequate criterium for DGF in terms of long-term outcome prediction, and a threshold effect in the lesions that ultimately results in long- term functional deficiency is suggested.